As the Co-Founder and Chief Innovation Officer at Cognetivity, I've dedicated my career to transforming cutting-edge scientific research into commercially viable and clinically validated AI healthcare solutions. Previously serving as Chief Scientific Officer, I took the helm in the journey from ideation to market entry for our core product, CognICA.
An alumnus of MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL), I also hold a PhD in Brain and Cognitive Sciences from Cambridge University. My multidisciplinary expertise spans R&D, Product Development, and Business Strategy, making me well-positioned to guide startups and established companies alike through the complex landscape of digital health.
Tap into my experience to accelerate your journey in healthcare innovation, technology commercialisation, and artificial intelligence applications.
Entering the U.S. market is a great strategic move, but it comes with its own set of challenges. I'd suggest starting with a small-scale pilot program to test market receptivity and cultural fit, especially in areas like leadership styles and operational norms. Pay attention to key metrics like user engagement and ROI.
Once you've fine-tuned your AI tool based on these initial insights, then you can ramp up your marketing efforts. But before you go all in, make sure you've considered regulatory compliance and data privacy laws specific to the U.S.